466 related articles for article (PubMed ID: 20303156)
21. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
Watts LA; Joseph N; Wallace M; Rauh-Hain JA; Muzikansky A; Growdon WB; del Carmen MG
Gynecol Oncol; 2009 Mar; 112(3):577-82. PubMed ID: 19150120
[TBL] [Abstract][Full Text] [Related]
22. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
23. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Arbyn M; Dillner J
J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
[TBL] [Abstract][Full Text] [Related]
24. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.
Vanslyke JG; Baum J; Plaza V; Otero M; Wheeler C; Helitzer DL
Qual Health Res; 2008 May; 18(5):584-96. PubMed ID: 18337618
[TBL] [Abstract][Full Text] [Related]
25. HPV vaccine acceptability in Ghana, West Africa.
Coleman MA; Levison J; Sangi-Haghpeykar H
Vaccine; 2011 May; 29(23):3945-50. PubMed ID: 21481327
[TBL] [Abstract][Full Text] [Related]
26. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
Keating KM; Brewer NT; Gottlieb SL; Liddon N; Ludema C; Smith JS
J Adolesc Health; 2008 Oct; 43(4 Suppl):S61-7. PubMed ID: 18809147
[TBL] [Abstract][Full Text] [Related]
27. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers.
Gerend MA; Shepherd MA; Lustria ML
Sex Transm Dis; 2013 May; 40(5):401-5. PubMed ID: 23588130
[TBL] [Abstract][Full Text] [Related]
28. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
Saslow D; Wheeler CM
Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
[TBL] [Abstract][Full Text] [Related]
30. Young adults and acceptance of the human papillomavirus vaccine.
Lenselink CH; Schmeink CE; Melchers WJ; Massuger LF; Hendriks JC; van Hamont D; Bekkers RL
Public Health; 2008 Dec; 122(12):1295-301. PubMed ID: 18619631
[TBL] [Abstract][Full Text] [Related]
31. The current and future role of screening in the era of HPV vaccination.
Myers E; Huh WK; Wright JD; Smith JS
Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
[TBL] [Abstract][Full Text] [Related]
32. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
[TBL] [Abstract][Full Text] [Related]
33. Decreasing risk: impact of HPV vaccination on outcomes.
Hymel PA
Am J Manag Care; 2006 Dec; 12(17 Suppl):S473-83. PubMed ID: 17203991
[TBL] [Abstract][Full Text] [Related]
34. Race, ethnicity and income as factors for HPV vaccine acceptance and use.
Jeudin P; Liveright E; del Carmen MG; Perkins RB
Hum Vaccin Immunother; 2013 Jul; 9(7):1413-20. PubMed ID: 23571170
[TBL] [Abstract][Full Text] [Related]
35. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.
Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Lo SS; Lee PW; Ngan HY
BJOG; 2009 Mar; 116(4):501-10. PubMed ID: 19250361
[TBL] [Abstract][Full Text] [Related]
36. Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong.
Lee PW; Kwan TT; Tam KF; Chan KK; Young PM; Lo SS; Cheung AN; Ngan HY
Prev Med; 2007; 45(2-3):130-4. PubMed ID: 17707077
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus vaccine: knowledge and attitudes in two Appalachian Kentucky counties.
Hopenhayn C; Christian A; Christian WJ; Schoenberg NE
Cancer Causes Control; 2007 Aug; 18(6):627-34. PubMed ID: 17497223
[TBL] [Abstract][Full Text] [Related]
38. Preparing for HPV vaccination in South Africa: key challenges and opinions.
Harries J; Moodley J; Barone MA; Mall S; Sinanovic E
Vaccine; 2009 Jan; 27(1):38-44. PubMed ID: 18977271
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
40. Age considerations when vaccinating against HPV.
Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]